{
    "nct_id": "NCT03899155",
    "age": "Adults",
    "cancer_center_accrual_goal_upper": 0,
    "curated_on": "2019-04-02",
    "study_start_date": "2019-08-09",
    "study_completion_date": "",
    "data_table4": "Interventional",
    "drug_list": {
        "drug": [
            {
                "drug_name": "Drug: Trametinib"
            },
            {
                "drug_name": "Drug: Regorafinib"
            },
            {
                "drug_name": "Drug: Oxaliplatin"
            },
            {
                "drug_name": "Drug: Daratumumab"
            },
            {
                "drug_name": "Drug: Temozolomide"
            },
            {
                "drug_name": "Drug: Cabozantinib"
            },
            {
                "drug_name": "Drug: Fluorouracil"
            },
            {
                "drug_name": "Drug: Nivolumab + Relatlimab"
            },
            {
                "drug_name": "Drug: Pemetrexed"
            },
            {
                "drug_name": "Drug: Leucovorin"
            },
            {
                "drug_name": "Drug: Pembrolizumab"
            },
            {
                "drug_name": "Drug: Bevacizumab"
            },
            {
                "drug_name": "Drug: Sunitinib"
            },
            {
                "drug_name": "Drug: Capecitabine"
            },
            {
                "drug_name": "Drug: Rucaparib"
            },
            {
                "drug_name": "Drug: Nivolumab"
            },
            {
                "drug_name": "Drug: Enzalutamide"
            },
            {
                "drug_name": "Drug: Relatlimab"
            },
            {
                "drug_name": "Drug: Ipilimumab"
            }
        ]
    },
    "long_title": "Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies",
    "last_updated": "2025-08-26",
    "management_group_list": {
        "management_group": [
            {
                "is_primary": "Y",
                "management_group_name": "Group1"
            }
        ]
    },
    "oncology_group_list": {
        "oncology_group": [
            {
                "group_name": "Group1",
                "is_primary": "N"
            }
        ]
    },
    "phase": "PHASE2",
    "principal_investigator": "NA",
    "principal_investigator_institution": "Bristol-Myers Squibb",
    "program_area_list": {
        "program_area": [
            {
                "is_primary": "Y",
                "program_area_name": "Program1"
            }
        ]
    },
    "protocol_id": 0,
    "protocol_ids": [],
    "protocol_no": "",
    "protocol_target_accrual": 1500,
    "protocol_type": "INTERVENTIONAL",
    "prior_treatment_requirements": [
        "Inclusion Criteria:",
        "* Signed Written Informed Consent.",
        "* Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.",
        "* On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.",
        "* WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.",
        "Exclude - Exclusion Criteria:",
        "Exclude - * Participant is not eligible for study treatment per the Parent Study eligibility criteria.",
        "Exclude - * Participants not receiving clinical benefit as assessed by the Investigator.",
        "Exclude - * Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.",
        "Exclude - * Other protocol-defined Inclusion/Exclusion Criteria apply"
    ],
    "short_title": "Pan Tumor Rollover Study",
    "site_list": {
        "site": []
    },
    "sponsor_list": {
        "sponsor": [
            {
                "is_principal_sponsor": "Y",
                "sponsor_name": "Bristol-Myers Squibb",
                "sponsor_protocol_no": "",
                "sponsor_roles": "sponsor"
            }
        ]
    },
    "staff_list": {
        "protocol_staff": []
    },
    "status": "open to accrual",
    "summary": "Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.",
    "treatment_list": {
        "step": [
            {
                "step_internal_id": 111,
                "step_code": "1",
                "step_type": "Registration",
                "arm": [
                    {
                        "arm_code": "A1: Nivolumab Monotherapy Dose 1",
                        "arm_internal_id": 0,
                        "arm_description": "A1: Nivolumab Monotherapy Dose 1",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "A2: Nivolumab Monotherapy Dose 2",
                        "arm_internal_id": 1,
                        "arm_description": "A2: Nivolumab Monotherapy Dose 2",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "B1: Nivolumab + Ipilimumab",
                        "arm_internal_id": 2,
                        "arm_description": "B1: Nivolumab + Ipilimumab",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Ipilimumab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "B2: Nivolumab + Ipilimumab + Cabozantinib",
                        "arm_internal_id": 3,
                        "arm_description": "B2: Nivolumab + Ipilimumab + Cabozantinib",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Ipilimumab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "2",
                                "level_description": "Drug: Cabozantinib",
                                "level_internal_id": 2,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "B3: Nivolumab + Ipilimumab + Trametinib",
                        "arm_internal_id": 4,
                        "arm_description": "B3: Nivolumab + Ipilimumab + Trametinib",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Ipilimumab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "2",
                                "level_description": "Drug: Trametinib",
                                "level_internal_id": 2,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C1: Relatlimab + Nivolumab Fixed Dose Combination Dose 1",
                        "arm_internal_id": 5,
                        "arm_description": "C1: Relatlimab + Nivolumab Fixed Dose Combination Dose 1",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab + Relatlimab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C3: Relatlimab + Nivolumab Fixed Dose Combination Dose 2",
                        "arm_internal_id": 6,
                        "arm_description": "C3: Relatlimab + Nivolumab Fixed Dose Combination Dose 2",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab + Relatlimab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C2: Relatlimab + Nivolumab Single Agent Vial (SAV) Dose 1",
                        "arm_internal_id": 7,
                        "arm_description": "C2: Relatlimab + Nivolumab Single Agent Vial (SAV) Dose 1",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C4: Relatlimab + Nivolumab SAV Dose 2",
                        "arm_internal_id": 8,
                        "arm_description": "C4: Relatlimab + Nivolumab SAV Dose 2",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C5: Relatlimab + Nivolumab + Ipilimumab",
                        "arm_internal_id": 9,
                        "arm_description": "C5: Relatlimab + Nivolumab + Ipilimumab",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Ipilimumab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C6: Relatlimab + Nivolumab + Capecitabine",
                        "arm_internal_id": 10,
                        "arm_description": "C6: Relatlimab + Nivolumab + Capecitabine",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab + Relatlimab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Capecitabine",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C7: Relatlimab + Nivolumab SAV Dose 3",
                        "arm_internal_id": 11,
                        "arm_description": "C7: Relatlimab + Nivolumab SAV Dose 3",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C10: Relatlimab + Nivolumab SAV Dose 4",
                        "arm_internal_id": 12,
                        "arm_description": "C10: Relatlimab + Nivolumab SAV Dose 4",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C12: Relatlimab + Nivolumab SAV Dose 5",
                        "arm_internal_id": 13,
                        "arm_description": "C12: Relatlimab + Nivolumab SAV Dose 5",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C8: Relatlimab + Nivolumab SAV + PDCT Dose 1",
                        "arm_internal_id": 14,
                        "arm_description": "C8: Relatlimab + Nivolumab SAV + PDCT Dose 1",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C9: Relatlimab + Nivolumab SAV + Bevacizumab",
                        "arm_internal_id": 15,
                        "arm_description": "C9: Relatlimab + Nivolumab SAV + Bevacizumab",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "2",
                                "level_description": "Drug: Bevacizumab",
                                "level_internal_id": 2,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "C11: Relatlimab + Nivolumab SAV + PDCT Dose 2",
                        "arm_internal_id": 16,
                        "arm_description": "C11: Relatlimab + Nivolumab SAV + PDCT Dose 2",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Relatlimab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "D1: Nivolumab + Temozolomide",
                        "arm_internal_id": 17,
                        "arm_description": "D1: Nivolumab + Temozolomide",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Temozolomide",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "D2: Nivolumab + Rucaparib",
                        "arm_internal_id": 18,
                        "arm_description": "D2: Nivolumab + Rucaparib",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Rucaparib",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "D3: Nivolumab + Daratumumab",
                        "arm_internal_id": 19,
                        "arm_description": "D3: Nivolumab + Daratumumab",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Daratumumab",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "D4: Nivolumab + Bevacizumab",
                        "arm_internal_id": 20,
                        "arm_description": "D4: Nivolumab + Bevacizumab",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Nivolumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E1: Bevacizumab Monotherapy",
                        "arm_internal_id": 21,
                        "arm_description": "E1: Bevacizumab Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Bevacizumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E2: Regorafinib Monotherapy",
                        "arm_internal_id": 22,
                        "arm_description": "E2: Regorafinib Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Regorafinib",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E4: Leucovorin + Oxaliplatin + Fluorouracil",
                        "arm_internal_id": 23,
                        "arm_description": "E4: Leucovorin + Oxaliplatin + Fluorouracil",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Leucovorin",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "1",
                                "level_description": "Drug: Fluorouracil",
                                "level_internal_id": 1,
                                "level_suspended": "N"
                            },
                            {
                                "level_code": "2",
                                "level_description": "Drug: Oxaliplatin",
                                "level_internal_id": 2,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E5: Enzalutamide Monotherapy",
                        "arm_internal_id": 24,
                        "arm_description": "E5: Enzalutamide Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Enzalutamide",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E6: Sunitinib Monotherapy",
                        "arm_internal_id": 25,
                        "arm_description": "E6: Sunitinib Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Sunitinib",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E7: Rucaparib Monotherapy",
                        "arm_internal_id": 26,
                        "arm_description": "E7: Rucaparib Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Rucaparib",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E8: Capecitabine Monotherapy",
                        "arm_internal_id": 27,
                        "arm_description": "E8: Capecitabine Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Capecitabine",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E9: Cabozantinib Monotherapy",
                        "arm_internal_id": 28,
                        "arm_description": "E9: Cabozantinib Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Cabozantinib",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E10: Pemetrexed Monotherapy",
                        "arm_internal_id": 29,
                        "arm_description": "E10: Pemetrexed Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Pemetrexed",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E11: Pembrolizumab Monotherapy",
                        "arm_internal_id": 30,
                        "arm_description": "E11: Pembrolizumab Monotherapy",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Pembrolizumab",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "E3: Leucovorin + Fluorouracil",
                        "arm_internal_id": 31,
                        "arm_description": "E3: Leucovorin + Fluorouracil",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Leucovorin",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    }
                ],
                "match": [
                    {
                        "and": [
                            {
                                "or": [
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "_LIQUID_"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "_SOLID_"
                                        }
                                    }
                                ]
                            },
                            {
                                "clinical": {
                                    "age_numerical": ">=18"
                                }
                            }
                        ]
                    }
                ]
            }
        ]
    }
}